| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.6M | -35.8% |
| Cost of Revenue | $578K | -55.0% |
| Gross Profit | $4.0M | -31.6% |
| R&D Expense | $6.6M | +4.0% |
| SG&A Expense | $8.0M | +10.2% |
| Operating Income | -$17.6M | -27.9% |
| Interest Expense | $2K | -99.8% |
| Pre-tax Income | -$13.5M | +32.6% |
| Income Tax | -$46K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.1M | +127.5% |
| Accounts Receivable | $789K | -53.2% |
| Current Assets | $12.8M | +81.3% |
| Total Assets | $32.4M | +2.0% |
| Current Liabilities | $5.8M | -50.3% |
| Total Liabilities | $18.4M | +13.8% |
| Stockholders' Equity | $14.0M | -10.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.4M | -41.7% |
| Capital Expenditures | $23K | -23.3% |
| Investing Cash Flow | -$23K | +23.3% |
| Financing Cash Flow | $16.6M | +178.2% |
| Free Cash Flow | -$10.4M | -41.5% |
| +92.8% |
| Net Income | -$13.5M | +30.6% |